ARWEN: Empowering Healthcare Organisations with Real-World Evidence
We unlock the value of real-world data by connecting forward-thinking hospitals and clinicians to a network that enables benchmarking, promotes collaboration and facilitates the sharing of treatment insights across different healthcare systems.
Benefits for sponsors
ARWEN provides sponsors with the latest treatment insights to enable more timely and better decision-making.
It achieves that by offering actionable insights into hospital data about:
ARWEN empowers governmental organisations to make insights-driven policy decisions that lead to optimisation of the balance between quality and cost of care.
We help you by:
What can ARWEN do for specific conditions?
It is of great added value to understand how effective a new drug is in different types of use cases. Real-world data is a requirement to reach reliable insights around drug uptake and drug effectiveness. For a condition like breast cancer, we offer a wide variety of insights, including:
We help stakeholders gain awareness of the current standard of care and drug use. We can provide our sponsors with precise insights into patient pathways for specific conditions, as well as epidemiology analyses. We can support sponsors better understand the impact of certain therapies, both on outcomes and on costs.
Other real-world evidence projects we run include market sizing and budget impact analyses in the drug discovery phase, identification of target cohorts and trial optimisation in the compound R&D phase, value demonstration, and KOL relations in the regulatory approval phase.
Solutions for specific conditions
With ARWEN, it is possible to run treatment improvement projects that are, by design, completely compliant with all legal requirements around ethics, data security, and privacy.
Don’t miss out on the opportunity to make informed decisions that lead to optimised patient care. Contact us today to learn more about how ARWEN can empower your organisation.
Contáctanos utilizando el formulario de contacto a continuación.